ENTITY
Mylan NV

Mylan NV (MYL US)

57
Analysis
Health Care • United States
Mylan NV is a global generic and specialty pharmaceuticals company. The Company operates an active pharmaceutical ingredient manufacturer and runs a specialty business focused on respiratory, allergy, and psychiatric therapies.
more
•18 Jan 2015 11:04

Never Trust A Swiss Central Banker

Post SNB surprise announcement yesterday - after leading the market on as recently as a few weeks ago on – the term “Never trust a Swiss central...

Share
bullish•Keppel
•31 Oct 2019 11:27

(Mostly) Asia M&A: October 2019 Roundup

For the month of October, 17 new deals were discussed on Smartkarma with an overall announced deal size of ~US$34bn. Clicking on the company...

Logo
764 Views
Share
•30 Sep 2019 11:33

(Mostly) Asia M&A: September 2019 Roundup

For the month of September, 12 new deals were discussed on Smartkarma with an overall announced deal size of ~US$250bn, aided by the mega-merger of...

Logo
749 Views
Share
bullish•Unizo Holdings
•30 Aug 2019 02:15

(Mostly) Asia M&A: August 2019 Roundup

For the month of August, 16 new deals were discussed on Smartkarma with an overall announced deal size of ~US$23bn. Clicking on the company name in...

Logo
834 Views
Share
bullish•Mylan NV
•15 Aug 2019 03:39

MergerTalk: Pfizer/Mylan -Don't Overdose on the Sector, but Mylan Over Teva Pair Trade Is Still On

The recently announced Reverse Morris Trust transaction involving the merger of Pfizer's  (PFE US) off-patent business (Upjohn) with Mylan (MYL US)...

Logo
681 Views
Share
x